About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On September 30, PhRMA was invited to the 2024 Fierce Biotech Summit, where Chief Public Affairs Officer and Head of Strategic Initiatives Robby Zirkelbach participated in the panel “The Strategic Powerhouse Within: The Case to Bring Communications Teams to the Table.” Robby discussed how communications teams contribute to strategic advocacy discussions, as well as the importance of managing internal and external stakeholder expectations.
When:
September 30, 2024, at 4:00 PM ET
Speakers:
- Natacha Gassenbach, Chief Communications Officer, Senior Vice President, Corporate Affairs, Biogen
- Kate O’Malley, Vice President, Corporate Affairs, Moderna
- Kym White, Chief Corporate Affairs Officer, Generate: Biomedicines
- Robby Zirkelbach, Chief Public Affairs Officer & Head of Strategic Initiatives, PhRMA
- Beth Roden, Senior Vice President and Head of Communications, U.S.; Head of Communications, Consumer Health, North America, Bayer (Moderator)